The Centers for Medicare & Medicaid Services last week announced the Medicare Advantage Valued-Based Insurance Design Model, which will test whether encouraging plan enrollees with certain conditions to consume high-value clinical services through reduced cost sharing and other approaches improves quality and reduces costs. Interventions will target enrollees with diabetes, chronic obstructive pulmonary disease, congestive heart failure, past stroke, coronary artery disease and mood disorders. Eligible MA and prescription drug plans in Arizona, Indiana, Iowa, Massachusetts, Oregon, Pennsylvania and Tennessee may submit proposals to participate in the model, which CMS expects to begin Jan. 1, 2017 and run for five years. The agency expects to post the Request for Applications soon at innovation.cms.gov/initiatives/VBID. For more information, see the CMS factsheet.

Related News Articles

Headline
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs…
Headline
The Centers for Medicare & Medicaid Services April 6 finalized updates and changes to its Medicare Advantage and Part D payment methodologies for calendar…
Headline
The Centers for Medicare & Medicaid Services should develop prior authorization measures for the Medicare Advantage Star Ratings Program to minimize care…
Headline
The Centers for Medicare & Medicaid Services today proposed changes to the Medicare Advantage and Medicare Part D programs, including implementing various…
Headline
The Centers for Medicare & Medicaid Services yesterday announced proposed changes to the risk adjustment model for Medicare Advantage organizations and…
Headline
Medicare Advantage organizations received $6.7 billion in risk adjustment payments in 2017 for diagnoses that were not supported by the medical record,…